(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced that it has received notice fro...any,s common stock will be,suspended as of Novembe...e,Securities and Exchange Commission, which will r..., unless the company files an appeal to the Nasdaq...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswire... ) today announced the approval of all of its,"fir...he District of Delaware,(the "Bankruptcy Court"). ...lief under Chapter 11 of the United States Bankrup... orders issued by the Bankruptcy Court allow the c...
(Date:11/24/2009)...HANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Bio...dministration (SFDA) has approved the,investigatio...n project,(Nodlin), an innovative insulin formulat...olaxy to initiate its first phase I clinical study... of high blood glucose and poor,metabolism. The co...
(Date:11/24/2009)...ary efficacy endpoint has been met for patients wi...cer, , QUEBEC CITY, Nov. 24 /PRNewswire-First...: AEZ) (the "Company"), a global biopharmaceutical..., today announced positive efficacy data from a Ph...njugate, AEZS-108 (formerly AN-152), in patients w...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4...GE, Tenn., Jan. 17, 2008 Scientific studies on cl...ng the 30 projects awarded more than 145 million p...ional Laboratory through the Department of Energys...ry and Experiment (INCITE) program. , Through I...ernment research facilities receive access to comp...
..., Holder Completes First Year Inspiring Others to ...tions, VALLEY FORGE, Pa., Jan. 17 In 2007, Good ... teamed up with "Iron Andy" Holder,as part of the ...n. Andy,set out to speak about living with diabete...ted with dozens of individuals who were inspired b...
...Previous Guidance for 2007, MADISON, N.J., Jan. 1...he nation,s leading provider of diagnostic,testing... report results,for the fourth quarter and year en...ce for 2008 on February 21, 2008, instead of the p...any is rescheduling its report of fourth quarter a...
Other Biology Technology:Oak Ridge leads DOE INCITE effort in 2008 2Oak Ridge leads DOE INCITE effort in 2008 3Oak Ridge leads DOE INCITE effort in 2008 4Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits 2Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits 3Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results 2Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results 3Bacterial Strain NM522, Glycerol Stock from Promega
Mounting Medium from R&D Systems
Cultrex BME with phenol red from Trevigen
Human Erythropoietin, Unconjugated from R&D Systems
Biology Products: